首页 > 最新文献

北京大学学报(医学版)最新文献

英文 中文
[Imaging study of osteogenesis in maxillary sinus segment of zygomatic implants]. 颧骨种植体上颌窦段成骨的影像学研究。
Q3 Medicine Pub Date : 2025-10-18
Ziyang Yu, Houzuo Guo, Xi Jiang, Weihua Han, Ye Lin

Objective: To assess the osteogenesis height in maxillary sinus segment one year after zygomatic implantation by imaging methods, and evaluate the influence of patient factors, maxillary sinus anatomical factors and surgical factors on postoperative osteogenesis height.

Methods: This study is a retrospective study, including patients who underwent zygomatic implantation and whose zygomatic implants passed through the maxillary sinus at the Department of Implantology, Peking University School and Hospital of Stomatology from July 2017 to January 2022. Preoperative and postoperative cone beam CT (CBCT)was taken to measure and calculate the average osteogenesis height (AOH) in maxillary sinus segment of the zygomatic implants, then the residual bone height, the width and morphology of the maxillary sinus floor in the buccal and palatal directions were measured. Besides, the integrity of Schneiderian membrane during implant surgery, and the general information of the patients and zygomatic implants were recorded. By comparing anatomical situations and surgical characteristics, the differences of AOH under different conditions were analyzed. Then AOH was divided into two groups (obvious osteogenesis group and non-obvious osteogenesis group) using the median as the threshold, and the influencing factors of osteogenesis were evaluated using mixed effect generalized linear model univariable and multivariable analysis.

Results: A total of 47 zygomatic implants were implanted in 24 patients. During the average follow-up period of 12.1 months, there was no implant failure, and the implant survival rate was 100%. Postoperative CBCT showed that 43 zygomatic implants had osteogenic images in the maxillary sinus segment, most of which originated from the floor of the maxillary sinus, and the median AOH was 3.1 mm [interquartile range (IQR): 4.0 mm]. In terms of maxillary sinus width, there were 31 cases (66.0%) of wide type and 16 cases (34.0%) of narrow type. In the aspect of buccal and palatal morphology, 17 cases were taper (36.2%), 20 cases were round (42.6%), and 10 cases were flat (21.3%). The median of residual bone height was 2.8 mm (IQR: 2.2 mm) before operation. Univa-riate analysis of mixed effect generalized linear model showed that postoperative obvious osteogenic rate was related to the residual bone height (OR=2.09, P=0.006). Multivariate analysis showed that the resi-dual bone height (OR=2.55, P=0.022) and the shape of a taper maxillary sinus (OR=11.44, P=0.040) had a significant impact on the postoperative obvious osteogenic rate.

Conclusion: The maxillary sinus floor showed osteogenic images 1 year after the zygomatic implantation surgery. Larger residual bone height and the shape of a taper maxillary sinus may be favorable factors for osteogenesis.

目的:通过影像学方法评估颧骨种植术后1年上颌窦段成骨高度,评价患者因素、上颌窦解剖因素和手术因素对术后成骨高度的影响。方法:本研究为回顾性研究,纳入2017年7月至2022年1月在北京大学口腔医学院种植科行颧种植体及颧种植体经上颌窦的患者。术前、术后采用锥形束CT (cone beam CT, CBCT)测量并计算颧种植体上颌窦段平均成骨高度(AOH),然后测量颊、腭方向上颌窦底残余骨高度、宽度和形态。同时记录种植术中施耐德膜的完整性、患者及颧骨种植体的一般信息。通过比较解剖情况和手术特点,分析不同情况下AOH的差异。然后以中位数为阈值将AOH分为明显成骨组和非明显成骨组,采用混合效应广义线性模型单变量和多变量分析评价成骨的影响因素。结果:24例患者共植入47个颧骨假体。平均随访12.1个月,无种植体失效,种植体成活率100%。术后CBCT显示43例颧种植体在上颌窦段可见成骨图像,大部分源自上颌窦底,中位AOH为3.1 mm[四分位间距(IQR): 4.0 mm]。上颌窦宽度方面,宽型31例(66.0%),窄型16例(34.0%)。在颊腭形态方面,锥形17例(36.2%),圆形20例(42.6%),扁平10例(21.3%)。术前残骨高度中位数为2.8 mm (IQR: 2.2 mm)。混合效应广义线性模型的单因素分析显示,术后明显成骨率与残骨高度相关(OR=2.09, P=0.006)。多因素分析显示,残双骨高度(OR=2.55, P=0.022)和锥形上颌窦形状(OR=11.44, P=0.040)对术后明显成骨率有显著影响。结论:颧种植术后1年上颌窦底出现成骨影像。较大的残余骨高度和锥形上颌窦的形状可能是成骨的有利因素。
{"title":"[Imaging study of osteogenesis in maxillary sinus segment of zygomatic implants].","authors":"Ziyang Yu, Houzuo Guo, Xi Jiang, Weihua Han, Ye Lin","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To assess the osteogenesis height in maxillary sinus segment one year after zygomatic implantation by imaging methods, and evaluate the influence of patient factors, maxillary sinus anatomical factors and surgical factors on postoperative osteogenesis height.</p><p><strong>Methods: </strong>This study is a retrospective study, including patients who underwent zygomatic implantation and whose zygomatic implants passed through the maxillary sinus at the Department of Implantology, Peking University School and Hospital of Stomatology from July 2017 to January 2022. Preoperative and postoperative cone beam CT (CBCT)was taken to measure and calculate the average osteogenesis height (AOH) in maxillary sinus segment of the zygomatic implants, then the residual bone height, the width and morphology of the maxillary sinus floor in the buccal and palatal directions were measured. Besides, the integrity of Schneiderian membrane during implant surgery, and the general information of the patients and zygomatic implants were recorded. By comparing anatomical situations and surgical characteristics, the differences of AOH under different conditions were analyzed. Then AOH was divided into two groups (obvious osteogenesis group and non-obvious osteogenesis group) using the median as the threshold, and the influencing factors of osteogenesis were evaluated using mixed effect generalized linear model univariable and multivariable analysis.</p><p><strong>Results: </strong>A total of 47 zygomatic implants were implanted in 24 patients. During the average follow-up period of 12.1 months, there was no implant failure, and the implant survival rate was 100%. Postoperative CBCT showed that 43 zygomatic implants had osteogenic images in the maxillary sinus segment, most of which originated from the floor of the maxillary sinus, and the median AOH was 3.1 mm [interquartile range (IQR): 4.0 mm]. In terms of maxillary sinus width, there were 31 cases (66.0%) of wide type and 16 cases (34.0%) of narrow type. In the aspect of buccal and palatal morphology, 17 cases were taper (36.2%), 20 cases were round (42.6%), and 10 cases were flat (21.3%). The median of residual bone height was 2.8 mm (IQR: 2.2 mm) before operation. Univa-riate analysis of mixed effect generalized linear model showed that postoperative obvious osteogenic rate was related to the residual bone height (<i>OR</i>=2.09, <i>P</i>=0.006). Multivariate analysis showed that the resi-dual bone height (<i>OR</i>=2.55, <i>P</i>=0.022) and the shape of a taper maxillary sinus (<i>OR</i>=11.44, <i>P</i>=0.040) had a significant impact on the postoperative obvious osteogenic rate.</p><p><strong>Conclusion: </strong>The maxillary sinus floor showed osteogenic images 1 year after the zygomatic implantation surgery. Larger residual bone height and the shape of a taper maxillary sinus may be favorable factors for osteogenesis.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 5","pages":"967-974"},"PeriodicalIF":0.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549351/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353667","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Protein biomarker screening and functional analysis of salivary exosomes in patients with ulcerative colitis]. 溃疡性结肠炎患者唾液外泌体的蛋白生物标志物筛选和功能分析
Q3 Medicine Pub Date : 2025-10-18
Congyi Yang, Xiaowen Zheng, Jingyi Chen, Jun Xu, Feng Chen, Yang Chen, Ning Chen
<p><strong>Objective: </strong>To identify protein markers that may be associated with ulcerative colitis (UC) by analyzing differential proteins in the salivary exosomes from newly diagnosed patients with active UC and healthy controls (HC), and to investigate the function of salivary exosome-specific high-expression proteins in UC patients and their potential role in the pathogenesis of UC.</p><p><strong>Methods: </strong>All patients and healthy controls were recruited from Peking University People' s Hospital. Whole saliva was obtained from 37 patients with newly diagnosed active ulcerative colitis (<i>n</i>=37) and apparently healthy controls (<i>n</i>=10). Salivary exosomes were extracted from samples, and the proteins within the exosomes were identified by liquid chromatograph-mass spectrometer (LC-MS/MS). The differentially expressed protein genes underwent gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) enrichment analysis using the DAVID tool. <i>In vitro</i>, macrophages were co-cultured with salivary exosomes from UC group and those from HC group, respectively, and real-time quantitative polymerase chain reaction (qPCR) was used to detect levels of CD80<sup>+</sup> and CD86<sup>+</sup>. Additionally, ELISA was performed to measure secretion levels of interleukin-6 (IL-6), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α) in the cell supernatant.</p><p><strong>Results: </strong>A total of 259 proteins were co-expressed in saliva exosomes from UC group and HC group, among which 11 proteins were highly expressed in the UC group, including PDIA4, A2M, EEF2, C3, PSMA2, PSMB6, PSMA1, IGHG1, IGHG3, IGHG4 and SERPING1, while 4 proteins were lowly expressed in UC group, including TCN1, SLPI and SERPING. Functional analysis of these 15 proteins, along with 129 specific proteins found only in the UC patients and 69 specific proteins found only in HC patients, respectively, was conducted using GO/KEGG. The results revealed that in the UC group, proteasome-related proteins such as PSMA1, PSMA2 and PSMB6 expressions were increased in salivary exosomes while many key molecules involved in complement cascade pathways, such as C3 were up-regu-lated. <i>In vitro</i> co-culture experiments demonstrated that compared with healthy controls, the salivary exosomes of the UC patients in active stage could play a pro-inflammatory role by promoting the transformation of macrophages into M1 type cells that secrete inflammatory factors IL-1β, IL-6 and TNF-α.</p><p><strong>Conclusion: </strong>Salivary exosomes in the UC patients may have the function of promoting inflammation. Analysis of protein levels in the saliva of the UC patients and healthy controls revealed significant differences in the expression levels of 15 co-expressed proteins between the two groups. Among them, C3, PSMA2, PSMB6 and PSMA1 were found to be mainly related to immune and inflammatory reactions in the UC group. These findings suggest that proteins with high s
目的:通过分析新诊断的活动性UC患者和健康对照组(HC)唾液外泌体的差异蛋白,发现可能与UC相关的蛋白标志物,探讨UC患者唾液外泌体特异性高表达蛋白的功能及其在UC发病机制中的潜在作用。方法:在北京大学人民医院招募所有患者和健康对照者。从37例新诊断为活动性溃疡性结肠炎的患者(n=37)和表面健康的对照组(n=10)中获得全唾液。提取唾液外泌体,采用液相色谱-质谱联用(LC-MS/MS)对外泌体中的蛋白质进行鉴定。差异表达蛋白基因使用DAVID工具进行基因本体(GO)和京都基因基因组百科全书(KEGG)富集分析。体外分别与UC组和HC组唾液外泌体共培养巨噬细胞,采用实时定量聚合酶链反应(qPCR)检测CD80+和CD86+水平。ELISA法检测细胞上清液中白细胞介素-6 (IL-6)、白细胞介素-1β (IL-1β)、肿瘤坏死因子-α (TNF-α)的分泌水平。结果:UC组和HC组唾液外泌体共表达259个蛋白,其中UC组高表达11个蛋白,包括PDIA4、A2M、EEF2、C3、PSMA2、PSMB6、PSMA1、IGHG1、IGHG3、IGHG4和SERPING1, UC组低表达4个蛋白,包括TCN1、SLPI和SERPING。使用GO/KEGG对这15种蛋白以及仅在UC患者中发现的129种特异性蛋白和仅在HC患者中发现的69种特异性蛋白进行功能分析。结果显示,UC组唾液外泌体中PSMA1、PSMA2、PSMB6等蛋白酶体相关蛋白表达增加,补体级联通路中C3等关键分子表达上调。体外共培养实验表明,与健康对照组相比,活动期UC患者唾液外泌体可通过促进巨噬细胞向分泌炎性因子IL-1β、IL-6和TNF-α的M1型细胞转化而发挥促炎作用。结论:UC患者唾液外泌体可能具有促炎作用。对UC患者和健康对照组唾液中蛋白质水平的分析显示,两组之间15种共表达蛋白的表达水平存在显著差异。其中C3、PSMA2、PSMB6、PSMA1在UC组中主要与免疫和炎症反应相关。这些发现表明,UC患者唾液外泌体中高特异性表达的蛋白有可能作为UC诊断的疾病标志物,并可能参与UC的发病机制。
{"title":"[Protein biomarker screening and functional analysis of salivary exosomes in patients with ulcerative colitis].","authors":"Congyi Yang, Xiaowen Zheng, Jingyi Chen, Jun Xu, Feng Chen, Yang Chen, Ning Chen","doi":"","DOIUrl":"","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Objective: &lt;/strong&gt;To identify protein markers that may be associated with ulcerative colitis (UC) by analyzing differential proteins in the salivary exosomes from newly diagnosed patients with active UC and healthy controls (HC), and to investigate the function of salivary exosome-specific high-expression proteins in UC patients and their potential role in the pathogenesis of UC.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;All patients and healthy controls were recruited from Peking University People' s Hospital. Whole saliva was obtained from 37 patients with newly diagnosed active ulcerative colitis (&lt;i&gt;n&lt;/i&gt;=37) and apparently healthy controls (&lt;i&gt;n&lt;/i&gt;=10). Salivary exosomes were extracted from samples, and the proteins within the exosomes were identified by liquid chromatograph-mass spectrometer (LC-MS/MS). The differentially expressed protein genes underwent gene ontology (GO) and Kyoto encyclopedia of genes and genomes (KEGG) enrichment analysis using the DAVID tool. &lt;i&gt;In vitro&lt;/i&gt;, macrophages were co-cultured with salivary exosomes from UC group and those from HC group, respectively, and real-time quantitative polymerase chain reaction (qPCR) was used to detect levels of CD80&lt;sup&gt;+&lt;/sup&gt; and CD86&lt;sup&gt;+&lt;/sup&gt;. Additionally, ELISA was performed to measure secretion levels of interleukin-6 (IL-6), interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α) in the cell supernatant.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 259 proteins were co-expressed in saliva exosomes from UC group and HC group, among which 11 proteins were highly expressed in the UC group, including PDIA4, A2M, EEF2, C3, PSMA2, PSMB6, PSMA1, IGHG1, IGHG3, IGHG4 and SERPING1, while 4 proteins were lowly expressed in UC group, including TCN1, SLPI and SERPING. Functional analysis of these 15 proteins, along with 129 specific proteins found only in the UC patients and 69 specific proteins found only in HC patients, respectively, was conducted using GO/KEGG. The results revealed that in the UC group, proteasome-related proteins such as PSMA1, PSMA2 and PSMB6 expressions were increased in salivary exosomes while many key molecules involved in complement cascade pathways, such as C3 were up-regu-lated. &lt;i&gt;In vitro&lt;/i&gt; co-culture experiments demonstrated that compared with healthy controls, the salivary exosomes of the UC patients in active stage could play a pro-inflammatory role by promoting the transformation of macrophages into M1 type cells that secrete inflammatory factors IL-1β, IL-6 and TNF-α.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;Salivary exosomes in the UC patients may have the function of promoting inflammation. Analysis of protein levels in the saliva of the UC patients and healthy controls revealed significant differences in the expression levels of 15 co-expressed proteins between the two groups. Among them, C3, PSMA2, PSMB6 and PSMA1 were found to be mainly related to immune and inflammatory reactions in the UC group. These findings suggest that proteins with high s","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 5","pages":"895-902"},"PeriodicalIF":0.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549370/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353790","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Clinical efficacy of arthroscopic medial patellofemoral complex reconstruction for recurrent patellar dislocation with high-grade trochlear dysplasia]. [关节镜下髌股内侧复合体重建治疗复发性髌骨脱位伴高度滑车发育不良的临床疗效]。
Q3 Medicine Pub Date : 2025-10-18
Fengyi Hu, Qingyang Meng, Nayun Chen, Jianing Wang, Zhenlong Liu, Yong Ma, Yuping Yang, Xi Gong, Cheng Wang, Ping Liu, Weili Shi

Objective: To investigate the midterm clinical efficacy of medial patellofemoral complex (MPFC) reconstruction for recurrent patellar dislocation with high-grade trochlear dysplasia.

Methods: A retrospective analysis was carried out among adult patients who underwent arthroscopically assisted MPFC reconstruction between January 2014 and December 2020. Dejour classification was evaluated to grade trochlear dysplasia; tibial tubercle-trochlear groove (TT-TG) distance and Insall-Salvati index were measured. Preoperative and postoperative patient-reported outcome measures (PROMs) were compared, including International Knee Documentation Committee (IKDC) score, Kujala score, Lysholm score and Tegner score. Information regarding returning-to-sport rate, re-instability events and complications was collected. Patellar tilt (PT), lateral patellar displacement (LPD) and bisect offset (BSO) ratio were measured based on axial computed tomography before and after surgery to assess the patellofemoral congruence.

Results: A total of 46 MPFC reconstructions in 43 patients were enrolled, including 16 male and 27 female. Mean age at surgery was (22.2±7.6) years (range: 14-44 years). Mean follow-up was (49.9±22.6) months (range: 18-102 months). The percentages of Dejour B, C and D dysplasia were 37.0% (17/46), 43.5% (20/46), and 19.6% (9/46), respectively. Mean Insall-Salvati index was 1.2±0.2 (range: 0.85-1.44), and mean TT-TG distance was (19.6±3.5) mm (range: 10.6-28.7 mm). At latest follow-up, there were significant improvements in all PROMs (P < 0.001): IKDC score, from 56.3±15.1 to 86.2±8.1; Kujala score, from 58.9±15.6 to 92.6±5.4; Lysholm score, from 63.7±15.0 to 94.0±5.7; Tegner score, from 3.1±1.4 to 4.7±1.4, and there were no significant differences in the improvements of the scores between the patients with Dejour B, C and D dysplasia. Overall, ninety percent of the patients returned to their preoperative sports level. One patient reported a postoperative subluxation, while no cases of infection, limited range of motion or patella fracture were observed. PT, LPD and BSO ratio were all significant altered (P < 0.001) after MPFC reconstruction.

Conclusion: Arthroscopically assisted MPFC reconstruction yielded satisfactory midterm clinical results for recurrent patellar dislocation with high-grade trochlear dysplasia. No significant differences of improvements in knee function were observed among the three types of high-grade trochlear dysplasia.

目的:探讨髌股内侧复合体(MPFC)重建术治疗复发性髌骨脱位伴高度滑车发育不良的中期临床疗效。方法:回顾性分析2014年1月至2020年12月期间接受关节镜辅助下MPFC重建的成年患者。Dejour分级评估滑车发育不良的分级;测量胫骨结节-滑车沟(TT-TG)距离和Insall-Salvati指数。比较术前和术后患者报告的预后指标(PROMs),包括国际膝关节文献委员会(IKDC)评分、Kujala评分、Lysholm评分和Tegner评分。收集有关恢复运动率、再不稳定事件和并发症的信息。术前、术后通过轴位ct测量髌骨倾斜(PT)、髌骨外侧位移(LPD)和等分偏移(BSO)比,评估髌股一致性。结果:共纳入43例患者46例MPFC重建,其中男性16例,女性27例。手术平均年龄为(22.2±7.6)岁(范围:14-44岁)。平均随访时间为(49.9±22.6)个月(18 ~ 102个月)。Dejour B、C、D发育不良比例分别为37.0%(17/46)、43.5%(20/46)、19.6%(9/46)。install - salvati指数平均值为1.2±0.2(范围:0.85 ~ 1.44),TT-TG距离平均值为(19.6±3.5)mm(范围:10.6 ~ 28.7 mm)。最新随访时,所有prom均有显著改善(P < 0.001): IKDC评分从56.3±15.1降至86.2±8.1;Kujala评分从58.9±15.6降至92.6±5.4;Lysholm评分从63.7±15.0降至94.0±5.7;Tegner评分从3.1±1.4到4.7±1.4,Dejour B、C、D型发育不良患者的评分改善无显著差异。总体而言,90%的患者恢复到术前运动水平。1例患者报告术后半脱位,无感染、活动范围受限或髌骨骨折。MPFC重建后PT、LPD、BSO比值均有显著改变(P < 0.001)。结论:关节镜辅助下的MPFC重建对复发性髌骨脱位伴高度滑车发育不良的中期临床效果满意。三种高度滑车发育不良患者的膝关节功能改善无显著差异。
{"title":"[Clinical efficacy of arthroscopic medial patellofemoral complex reconstruction for recurrent patellar dislocation with high-grade trochlear dysplasia].","authors":"Fengyi Hu, Qingyang Meng, Nayun Chen, Jianing Wang, Zhenlong Liu, Yong Ma, Yuping Yang, Xi Gong, Cheng Wang, Ping Liu, Weili Shi","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the midterm clinical efficacy of medial patellofemoral complex (MPFC) reconstruction for recurrent patellar dislocation with high-grade trochlear dysplasia.</p><p><strong>Methods: </strong>A retrospective analysis was carried out among adult patients who underwent arthroscopically assisted MPFC reconstruction between January 2014 and December 2020. Dejour classification was evaluated to grade trochlear dysplasia; tibial tubercle-trochlear groove (TT-TG) distance and Insall-Salvati index were measured. Preoperative and postoperative patient-reported outcome measures (PROMs) were compared, including International Knee Documentation Committee (IKDC) score, Kujala score, Lysholm score and Tegner score. Information regarding returning-to-sport rate, re-instability events and complications was collected. Patellar tilt (PT), lateral patellar displacement (LPD) and bisect offset (BSO) ratio were measured based on axial computed tomography before and after surgery to assess the patellofemoral congruence.</p><p><strong>Results: </strong>A total of 46 MPFC reconstructions in 43 patients were enrolled, including 16 male and 27 female. Mean age at surgery was (22.2±7.6) years (range: 14-44 years). Mean follow-up was (49.9±22.6) months (range: 18-102 months). The percentages of Dejour B, C and D dysplasia were 37.0% (17/46), 43.5% (20/46), and 19.6% (9/46), respectively. Mean Insall-Salvati index was 1.2±0.2 (range: 0.85-1.44), and mean TT-TG distance was (19.6±3.5) mm (range: 10.6-28.7 mm). At latest follow-up, there were significant improvements in all PROMs (<i>P</i> < 0.001): IKDC score, from 56.3±15.1 to 86.2±8.1; Kujala score, from 58.9±15.6 to 92.6±5.4; Lysholm score, from 63.7±15.0 to 94.0±5.7; Tegner score, from 3.1±1.4 to 4.7±1.4, and there were no significant differences in the improvements of the scores between the patients with Dejour B, C and D dysplasia. Overall, ninety percent of the patients returned to their preoperative sports level. One patient reported a postoperative subluxation, while no cases of infection, limited range of motion or patella fracture were observed. PT, LPD and BSO ratio were all significant altered (<i>P</i> < 0.001) after MPFC reconstruction.</p><p><strong>Conclusion: </strong>Arthroscopically assisted MPFC reconstruction yielded satisfactory midterm clinical results for recurrent patellar dislocation with high-grade trochlear dysplasia. No significant differences of improvements in knee function were observed among the three types of high-grade trochlear dysplasia.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 5","pages":"947-955"},"PeriodicalIF":0.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549348/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Construction and application of oral squamous cell carcinoma organoid bank]. 口腔鳞状细胞癌类器官库的构建与应用
Q3 Medicine Pub Date : 2025-10-18
Shang Xie, Luming Wang, Xinyuan Zhang, Qiushi Feng, Yangyang Xia, Ziwei Dai, Xiaofeng Shan, Zhigang Cai

Oral squamous cell carcinoma (OSCC) accounts for over 90% of oral malignancies, with more than 370 000 new cases and approximately 188 000 deaths annually worldwide. In China, there are roughly 65 000 new cases and 35 000 deaths each year, showing a significant upward trend compared with 2015 statistics. Despite continuous advancements in treatment modalities, the 5-year survival rate remains stagnant at 50%-60%, where tumor heterogeneity and therapy resistance persist as fundamental barriers to precision oncology. To address these critical challenges, this study established a standardized bioban-king protocol for OSCC patient-derived organoids (PDOs) (Patent: Method for constructing an oral squamous cell carcinoma organoid bank, ZL202311378598.3). Through groundbreaking optimization of culture media, enzymatic digestion kinetics, and stepwise cryopreservation, we achieved a biobanking success rate exceeding 95% and pioneered synchronous cultivation of matched primary tumors, lymph node metastases, and adjacent normal mucosa from individual patients, preserving spatial heterogeneity and stromal interactions. Leveraging this platform, we developed high-throughput drug screening: Quantified heterogeneity-driven differential chemoresponse using adenosine triphosphate (ATP)-based viability assays; We discovered resistance mechanisms: Identified sialylated cancer IgG (SIA-cIgG)-mediated cis-platin resistance (primary/secondary) through PTPN13 suppression, with anti-SIA-cIgG combination therapy demonstrating synergistic efficacy. Besides, we elucidated metastatic drivers: CRISPR-Cas9-edited organoids revealed WDR54 promoted metastasis via H3K4me3/H4K16ac epigenetic reprogramming, activating epithelial-mesenchymal plasticity (EMP) and inducing partial epithelial-mesenchymal transition (pEMT). This "holographic patient-mirroring" platform provided unprecedented resolution for OSCC precision therapy and had been formally incorporated into the Chinese Stomatological Association Technical Guidelines (Technical guideline for establishing patient-derived oral squamous cell carcinoma organoid banks, CHSA 2024-08). Future integration of immune-competent organoids, 3D-bioprinted vasculature, and multi-omics-AI systems will accelerate personalized oncology. These innovations will accelerate clinical translation of personalized therapeutic regimens, ultimately bridging the gap between bench research and bedside application.

口腔鳞状细胞癌(OSCC)占口腔恶性肿瘤的90%以上,全世界每年有37万多例新发病例和大约18.8万例死亡。在中国,每年约有6.5万例新发病例和3.5万例死亡,与2015年的统计数据相比,呈显著上升趋势。尽管治疗方式不断进步,但5年生存率仍然停滞在50%-60%,肿瘤异质性和治疗耐药性仍然是实现精准肿瘤的根本障碍。为了解决这些关键挑战,本研究为OSCC患者来源的类器官(PDOs)建立了标准化的生物样本王方案(专利:构建口腔鳞状细胞癌类器官库的方法,ZL202311378598.3)。通过开创性地优化培养基、酶消化动力学和逐步冷冻保存,我们实现了超过95%的生物银行成功率,并开创了同步培养匹配的原发肿瘤、淋巴结转移瘤和个体患者的邻近正常粘膜,保持了空间异质性和间质相互作用。利用这个平台,我们开发了高通量药物筛选:使用基于三磷酸腺苷(ATP)的活力分析来量化异质性驱动的差异化学反应;我们发现了耐药机制:通过抑制PTPN13发现唾液化癌IgG (SIA-cIgG)介导的顺铂耐药(原发性/继发性),抗SIA-cIgG联合治疗显示出协同效应。此外,我们还阐明了转移驱动因素:crispr - cas9编辑的类器官显示,WDR54通过H3K4me3/H4K16ac表观遗传重编程促进转移,激活上皮-间质可塑性(EMP)并诱导部分上皮-间质转化(pEMT)。该“全息患者镜像”平台为OSCC精准治疗提供了前所未有的分辨率,并已正式纳入中国口腔医学会技术指南(《建立患者源性口腔鳞状细胞癌类器官库技术指南》,CHSA 2024-08)。未来免疫类器官、3d生物打印血管系统和多组学-人工智能系统的整合将加速个性化肿瘤学的发展。这些创新将加速个性化治疗方案的临床转化,最终弥合实验室研究和床边应用之间的差距。
{"title":"[Construction and application of oral squamous cell carcinoma organoid bank].","authors":"Shang Xie, Luming Wang, Xinyuan Zhang, Qiushi Feng, Yangyang Xia, Ziwei Dai, Xiaofeng Shan, Zhigang Cai","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Oral squamous cell carcinoma (OSCC) accounts for over 90% of oral malignancies, with more than 370 000 new cases and approximately 188 000 deaths annually worldwide. In China, there are roughly 65 000 new cases and 35 000 deaths each year, showing a significant upward trend compared with 2015 statistics. Despite continuous advancements in treatment modalities, the 5-year survival rate remains stagnant at 50%-60%, where tumor heterogeneity and therapy resistance persist as fundamental barriers to precision oncology. To address these critical challenges, this study established a standardized bioban-king protocol for OSCC patient-derived organoids (PDOs) (Patent: Method for constructing an oral squamous cell carcinoma organoid bank, ZL202311378598.3). Through groundbreaking optimization of culture media, enzymatic digestion kinetics, and stepwise cryopreservation, we achieved a biobanking success rate exceeding 95% and pioneered synchronous cultivation of matched primary tumors, lymph node metastases, and adjacent normal mucosa from individual patients, preserving spatial heterogeneity and stromal interactions. Leveraging this platform, we developed high-throughput drug screening: Quantified heterogeneity-driven differential chemoresponse using adenosine triphosphate (ATP)-based viability assays; We discovered resistance mechanisms: Identified sialylated cancer IgG (SIA-cIgG)-mediated cis-platin resistance (primary/secondary) through PTPN13 suppression, with anti-SIA-cIgG combination therapy demonstrating synergistic efficacy. Besides, we elucidated metastatic drivers: CRISPR-Cas9-edited organoids revealed WDR54 promoted metastasis <i>via</i> H3K4me3/H4K16ac epigenetic reprogramming, activating epithelial-mesenchymal plasticity (EMP) and inducing partial epithelial-mesenchymal transition (pEMT). This \"holographic patient-mirroring\" platform provided unprecedented resolution for OSCC precision therapy and had been formally incorporated into the Chinese Stomatological Association Technical Guidelines (Technical guideline for establishing patient-derived oral squamous cell carcinoma organoid banks, CHSA 2024-08). Future integration of immune-competent organoids, 3D-bioprinted vasculature, and multi-omics-AI systems will accelerate personalized oncology. These innovations will accelerate clinical translation of personalized therapeutic regimens, ultimately bridging the gap between bench research and bedside application.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 5","pages":"847-851"},"PeriodicalIF":0.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549350/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Current situation and exploration of clinical transformation of plasmatrix in oral implantology]. 口腔种植中质基质临床转化的现状与探索
Q3 Medicine Pub Date : 2025-10-18
Yulan Wang, Hao Zeng, Yufeng Zhang

With the rapid development of implant dentistry, increasing attention has been paid to the long-term stability and aesthetic outcomes of dental implants, among which sufficient volume and quality of soft and hard tissues are considered crucial contributing factors for successful treatment outcomes. Among the various available tissue regeneration strategies, plasmatrix, an autologous biomaterial derived from the patient ' s own peripheral blood, has demonstrated unique and significant clinical value in the regeneration and augmentation of both soft and hard tissues associated with dental implant therapy in recent years. This notable potential is primarily attributed to its rich content of multiple growth factors, viable cells, and a supportive fibrin scaffold, along with its excellent biocompatibility, tunable biodegradation profile, and a relatively simple and rapid preparation process that does not require complex laboratory equipment. As a result, its clinical applications have been continuously expanding across a wide range of indications. Based on a comprehensive review of the existing literature and current research evidence, this article provides an in-depth summary of the advancements in both basic science and clinical applications of plasmatrix in the context of implant dentistry. Particular attention is given to its classification from a materials science perspective, underlying molecular mechanisms, biological effects in promoting tissue regeneration, and its implementation under different clinical scenarios. Furthermore, the article discusses unresolved technical challenges and existing controversies, and outlines potential future directions for research and technological innovation, aiming to provide robust evidence-based guidance for clinical practice as well as a theoretical and methodological reference for future scientific investigations.

随着种植牙科的快速发展,种植体的长期稳定性和美观性越来越受到人们的关注,其中软硬组织的足够体积和质量被认为是成功治疗结果的关键因素。血浆基质是一种来源于患者自身外周血的自体生物材料,近年来在牙种植治疗中软组织和硬组织的再生和增强方面显示出独特而重要的临床价值。这种显著的潜力主要归功于其丰富的多种生长因子、活细胞和支持性纤维蛋白支架的含量,以及其出色的生物相容性、可调节的生物降解特征,以及相对简单和快速的制备过程,不需要复杂的实验室设备。因此,其临床应用已不断扩大在广泛的适应症。本文在对现有文献和研究证据进行综合综述的基础上,对质基质在种植牙医学的基础科学和临床应用方面的进展进行了深入的总结。特别关注其从材料科学角度的分类,潜在的分子机制,促进组织再生的生物学效应,以及在不同临床情况下的应用。此外,本文还讨论了尚未解决的技术挑战和存在的争议,并概述了未来研究和技术创新的潜在方向,旨在为临床实践提供强有力的循证指导,并为未来的科学研究提供理论和方法参考。
{"title":"[Current situation and exploration of clinical transformation of plasmatrix in oral implantology].","authors":"Yulan Wang, Hao Zeng, Yufeng Zhang","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>With the rapid development of implant dentistry, increasing attention has been paid to the long-term stability and aesthetic outcomes of dental implants, among which sufficient volume and quality of soft and hard tissues are considered crucial contributing factors for successful treatment outcomes. Among the various available tissue regeneration strategies, plasmatrix, an autologous biomaterial derived from the patient ' s own peripheral blood, has demonstrated unique and significant clinical value in the regeneration and augmentation of both soft and hard tissues associated with dental implant therapy in recent years. This notable potential is primarily attributed to its rich content of multiple growth factors, viable cells, and a supportive fibrin scaffold, along with its excellent biocompatibility, tunable biodegradation profile, and a relatively simple and rapid preparation process that does not require complex laboratory equipment. As a result, its clinical applications have been continuously expanding across a wide range of indications. Based on a comprehensive review of the existing literature and current research evidence, this article provides an in-depth summary of the advancements in both basic science and clinical applications of plasmatrix in the context of implant dentistry. Particular attention is given to its classification from a materials science perspective, underlying molecular mechanisms, biological effects in promoting tissue regeneration, and its implementation under different clinical scenarios. Furthermore, the article discusses unresolved technical challenges and existing controversies, and outlines potential future directions for research and technological innovation, aiming to provide robust evidence-based guidance for clinical practice as well as a theoretical and methodological reference for future scientific investigations.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 5","pages":"836-840"},"PeriodicalIF":0.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549343/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Three-dimensional morphological analysis of posed smile]. 摆姿微笑的三维形态分析
Q3 Medicine Pub Date : 2025-10-18
Yujia Xiao, Bochun Mao, Yanheng Zhou

Objective: To investigate the changes and symmetry of facial soft tissue during posed smile, to analyze the feature of posed smile in different gender, and verify the reproducibility of posed smile.

Methods: Three-dimensional (3D) facial images of 41 adults (16 males and 25 females with an average age of 26.76±2.70 years) which were taken by FaceScan three-dimensional sensor, including one rest position and two posed smile images. Then these images were imported into 3D soft tissue analysis software for model repositioning. 3D morphable model method (3DMM) was carried out to automatic landmarks setting. After that, the measurement of the eyes, cheeks, nose and perioral area were carried out for 3D soft tissue analysis. Finally, the changes and symmetry of the soft tissues between the two expression states and the gender differences during the posed smiles were compared. Meanwhile, the reproducibility of posed smile was statistically tested.

Results: Compared with the rest position, except for nasolabial angle (1.45°±7.65°), the measurements of 3D soft tissue in other region were changed in posed smile (P < 0.001). It should be noted that the eye region was also significantly changed (P < 0.001). Furthermore, the prominent feature of posed smile was that the alar base length became longer, the upper and lower vermilions were narrow and thin, and the mentolabial furrows became shallow. Meanwhile the chin extended anteriorly while the mouth retracted; During posed smile, the labial fissure asymmetry [2.78 (1.73, 3.49) mm], mid-infraorbital asymmetry [2.36 (1.22, 3.27) mm] and outercanthal asymmetry [2.31(1.29, 2.80) mm] were most apparent. Compared with the rest position, the asymmetry was not significantly increased except for cheilion and alar curvature points during the posed smile (P>0.05). In the posed smile, the changes of the right palpebral fissure height and the thickness of lower vermilion (|Li-Stoi| z) of males were greater than those of females (P < 0.05), and asymmetry of exocanthion and cheekbone increased more than that of females (P < 0.05). There was no obvious difference between the two posed smiles.

Conclusion: In this study, during the posed smile the soft tissues of the eyes, cheeks, nose, lips and chin changed in different degrees, and the asymmetry of cheilion and alar curvature point was greater than that of the rest position; In addition, the reproducibility of posed smile was excellent, which can be a reference for clinical aesthetics and functional research of smile.

目的:探讨摆笑过程中面部软组织的变化和对称性,分析不同性别摆笑的特征,验证摆笑的可重复性。方法:采用FaceScan三维传感器采集41例成人(男16例,女25例,平均年龄26.76±2.70岁)的三维面部图像,包括1张休息位和2张摆姿微笑图像。然后将这些图像导入三维软组织分析软件中进行模型重新定位。采用三维变形模型法(3DMM)实现地标自动设置。然后测量眼睛、脸颊、鼻子和口周区域进行三维软组织分析。最后,比较了两种表情状态下软组织的变化和对称性,以及摆姿势微笑时的性别差异。同时,对摆姿微笑的再现性进行了统计检验。结果:与休息位相比,摆姿微笑时除鼻唇角(1.45°±7.65°)外,其他部位的三维软组织测量值均有变化(P < 0.001)。值得注意的是,眼部区域也发生了显著变化(P < 0.001)。此外,摆姿势微笑的显著特征是鼻翼基部变长,上下朱红变细窄,颏沟变浅。与此同时,下巴向前伸展,嘴巴收缩;在摆姿势微笑时,唇裂不对称[2.78 (1.73,3.49)mm]、中眶下不对称[2.36 (1.22,3.27)mm]和外眦不对称[2.31(1.29,2.80)mm]最为明显。摆姿微笑时,除鼻翼和鼻翼曲率点外,面部不对称性均未显著增加(P < 0.05)。在摆姿微笑时,男性右睑裂高度和下朱砂厚度(|Li-Stoi| z)的变化大于女性(P < 0.05),外翻和颧骨的不对称性增加大于女性(P < 0.05)。这两个人摆出的微笑没有明显的区别。结论:在本研究中,摆姿微笑时,眼睛、脸颊、鼻子、嘴唇和下巴的软组织都有不同程度的变化,鼻翼和鼻翼曲率点的不对称性大于休息位;此外,摆姿微笑的再现性良好,可为临床美学和微笑功能研究提供参考。
{"title":"[Three-dimensional morphological analysis of posed smile].","authors":"Yujia Xiao, Bochun Mao, Yanheng Zhou","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the changes and symmetry of facial soft tissue during posed smile, to analyze the feature of posed smile in different gender, and verify the reproducibility of posed smile.</p><p><strong>Methods: </strong>Three-dimensional (3D) facial images of 41 adults (16 males and 25 females with an average age of 26.76±2.70 years) which were taken by FaceScan three-dimensional sensor, including one rest position and two posed smile images. Then these images were imported into 3D soft tissue analysis software for model repositioning. 3D morphable model method (3DMM) was carried out to automatic landmarks setting. After that, the measurement of the eyes, cheeks, nose and perioral area were carried out for 3D soft tissue analysis. Finally, the changes and symmetry of the soft tissues between the two expression states and the gender differences during the posed smiles were compared. Meanwhile, the reproducibility of posed smile was statistically tested.</p><p><strong>Results: </strong>Compared with the rest position, except for nasolabial angle (1.45°±7.65°), the measurements of 3D soft tissue in other region were changed in posed smile (<i>P</i> < 0.001). It should be noted that the eye region was also significantly changed (<i>P</i> < 0.001). Furthermore, the prominent feature of posed smile was that the alar base length became longer, the upper and lower vermilions were narrow and thin, and the mentolabial furrows became shallow. Meanwhile the chin extended anteriorly while the mouth retracted; During posed smile, the labial fissure asymmetry [2.78 (1.73, 3.49) mm], mid-infraorbital asymmetry [2.36 (1.22, 3.27) mm] and outercanthal asymmetry [2.31(1.29, 2.80) mm] were most apparent. Compared with the rest position, the asymmetry was not significantly increased except for cheilion and alar curvature points during the posed smile (<i>P</i>>0.05). In the posed smile, the changes of the right palpebral fissure height and the thickness of lower vermilion (|Li-Stoi| <sub>z</sub>) of males were greater than those of females (<i>P</i> < 0.05), and asymmetry of exocanthion and cheekbone increased more than that of females (<i>P</i> < 0.05). There was no obvious difference between the two posed smiles.</p><p><strong>Conclusion: </strong>In this study, during the posed smile the soft tissues of the eyes, cheeks, nose, lips and chin changed in different degrees, and the asymmetry of cheilion and alar curvature point was greater than that of the rest position; In addition, the reproducibility of posed smile was excellent, which can be a reference for clinical aesthetics and functional research of smile.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 5","pages":"989-995"},"PeriodicalIF":0.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549365/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Effect of the combination of alkaloids from Euodiae Fructus and berberine in Zuojin Pill on cytotoxicity in HepG2 cells]. [左金丸中枸杞子生物碱与小檗碱联合对HepG2细胞毒性的影响]。
Q3 Medicine Pub Date : 2025-10-18
Yadong Gao, An Zhu, Ludi Li, Yingzi Li, Qi Wang

Objective: To investigate the hepatotoxicity of alkaloids from Euodiae Fructus combined with berberine (BBR) in Zuojin Pill, and to preliminarily explore the possible detoxification mechanism of the combination components.

Methods: The combination ratio of components was determined by the maximum concentration (Cmax) of the chemical components in Zuojin Pill. HepG2 cell model was used to investigate the combined toxicity of the hepatotoxic components from Euodiae Fructus, such as evodiamine (EVO) or dehydroevodiamine (DHED), with BBR for 48 h. The experimental groups were set as follows: the vehicle control group, the EVO group, the DHED group, the BBR group, and the combination group of EVO or DHED with BBR. The cell counting kit-8 (CCK-8) method was used to determine the cell viability, and the combination index (CI) was used to determine the combined toxicity of the components. The alanine transaminase (ALT), aspartate aminotransferase (AST), lactate dehydroge-nase (LDH), and alkaline phosphatase (ALP) activities as well as total bilirubin (TBIL) content in the cell culture supernatant were detected. The protein expression levels of bile acid transporters, such as bile salt export pump (BSEP) and multidrug resistance-associated protein 2 (MRP2), were detected by Western blot. The intracellular malondialdehyde (MDA) content and superoxide dismutase (SOD) activity in HepG2 cells were detected.

Results: Compared with EVO or DHED group, the combination of EVO 1 μmol/L with BBR 10 μmol/L or DHED 50 μmol/L with BBR 35 μmol/L significantly increased cell viability of HepG2 cells (P < 0.01), with CI values of 77.89 or 4.49, respectively, much greater than 1. Significant decreases in the activities of ALT, AST, LDH, ALP, and TBIL content in the cell culture supernatant were found in both combination groups (P < 0.05, P < 0.01). Compared with the EVO group, the combination of EVO with BBR upregulated the protein expression levels of BSEP and MRP2. Compared with the DHED group, the combination of DHED with BBR significantly downregulated the protein expression levels of BSEP and MRP2 (P < 0.01). Compared with EVO or DHED group, the combination of EVO or DHED with BBR significantly reduced the MDA content in HepG2 cells (P < 0.05, P < 0.01).

Conclusion: A certain ratio of BBR combined with EVO or DHED had an antagonistic effect on HepG2 cytotoxicity, which might be related to regulating the expression of bile acid transpor-ters, and reducing lipid peroxidation damage.

目的:考察左金丸中乌桕生物碱与小檗碱(BBR)联合使用的肝毒性,并初步探讨联合成分可能的解毒机制。方法:采用左金丸中各化学成分的最大浓度(Cmax)测定各成分的组合比。采用HepG2细胞模型,研究茱萸肝毒性成分evolodiamine (EVO)或dehydroevolodiamine (DHED)与BBR联合作用48 h。实验组设置为:载药对照组、EVO组、DHED组、BBR组、EVO或DHED与BBR联合作用组。采用细胞计数试剂盒-8 (CCK-8)法测定细胞活力,采用联合指数(CI)法测定各组分的联合毒性。检测细胞培养上清液中谷丙转氨酶(ALT)、天冬氨酸转氨酶(AST)、乳酸脱氢酶(LDH)、碱性磷酸酶(ALP)活性及总胆红素(TBIL)含量。Western blot检测胆汁酸转运体胆汁盐输出泵(BSEP)和多药耐药相关蛋白2 (MRP2)的蛋白表达水平。检测HepG2细胞内丙二醛(MDA)含量和超氧化物歧化酶(SOD)活性。结果:与EVO或DHED组相比,EVO 1 μmol/L与BBR 10 μmol/L或DHED 50 μmol/L与BBR 35 μmol/L联合使用可显著提高HepG2细胞的细胞活力(P < 0.01), CI值分别为77.89和4.49,远大于1。两组细胞培养上清中ALT、AST、LDH、ALP和TBIL活性均显著降低(P < 0.05, P < 0.01)。与EVO组相比,EVO联合BBR组上调了BSEP和MRP2蛋白的表达水平。与DHED组相比,DHED联合BBR显著下调BSEP、MRP2蛋白表达水平(P < 0.01)。与EVO或DHED组比较,EVO或DHED联合BBR组HepG2细胞MDA含量显著降低(P < 0.05, P < 0.01)。结论:一定比例BBR联合EVO或DHED对HepG2细胞毒性具有拮抗作用,其机制可能与调节胆汁酸转运体的表达、减轻脂质过氧化损伤有关。
{"title":"[Effect of the combination of alkaloids from Euodiae Fructus and berberine in Zuojin Pill on cytotoxicity in HepG2 cells].","authors":"Yadong Gao, An Zhu, Ludi Li, Yingzi Li, Qi Wang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the hepatotoxicity of alkaloids from Euodiae Fructus combined with berberine (BBR) in Zuojin Pill, and to preliminarily explore the possible detoxification mechanism of the combination components.</p><p><strong>Methods: </strong>The combination ratio of components was determined by the maximum concentration (Cmax) of the chemical components in Zuojin Pill. HepG2 cell model was used to investigate the combined toxicity of the hepatotoxic components from Euodiae Fructus, such as evodiamine (EVO) or dehydroevodiamine (DHED), with BBR for 48 h. The experimental groups were set as follows: the vehicle control group, the EVO group, the DHED group, the BBR group, and the combination group of EVO or DHED with BBR. The cell counting kit-8 (CCK-8) method was used to determine the cell viability, and the combination index (CI) was used to determine the combined toxicity of the components. The alanine transaminase (ALT), aspartate aminotransferase (AST), lactate dehydroge-nase (LDH), and alkaline phosphatase (ALP) activities as well as total bilirubin (TBIL) content in the cell culture supernatant were detected. The protein expression levels of bile acid transporters, such as bile salt export pump (BSEP) and multidrug resistance-associated protein 2 (MRP2), were detected by Western blot. The intracellular malondialdehyde (MDA) content and superoxide dismutase (SOD) activity in HepG2 cells were detected.</p><p><strong>Results: </strong>Compared with EVO or DHED group, the combination of EVO 1 μmol/L with BBR 10 μmol/L or DHED 50 μmol/L with BBR 35 μmol/L significantly increased cell viability of HepG2 cells (<i>P</i> < 0.01), with CI values of 77.89 or 4.49, respectively, much greater than 1. Significant decreases in the activities of ALT, AST, LDH, ALP, and TBIL content in the cell culture supernatant were found in both combination groups (<i>P</i> < 0.05, <i>P</i> < 0.01). Compared with the EVO group, the combination of EVO with BBR upregulated the protein expression levels of BSEP and MRP2. Compared with the DHED group, the combination of DHED with BBR significantly downregulated the protein expression levels of BSEP and MRP2 (<i>P</i> < 0.01). Compared with EVO or DHED group, the combination of EVO or DHED with BBR significantly reduced the MDA content in HepG2 cells (<i>P</i> < 0.05, <i>P</i> < 0.01).</p><p><strong>Conclusion: </strong>A certain ratio of BBR combined with EVO or DHED had an antagonistic effect on HepG2 cytotoxicity, which might be related to regulating the expression of bile acid transpor-ters, and reducing lipid peroxidation damage.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 5","pages":"926-933"},"PeriodicalIF":0.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549360/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Prognostic analysis of laparoscopic simultaneous radical cystectomy and nephroureterectomy]. [腹腔镜同时根治性膀胱切除术和肾输尿管切除术预后分析]。
Q3 Medicine Pub Date : 2025-10-18
Shenmo Li, Dandan Su, Jiyu Lin, Haodong Song, Lulin Ma, Xiaofei Hou, Guoliang Wang, Hongxian Zhang, Jianfei Ye, Shudong Zhang

Objective: To investigate the safety and prognostic factors influencing the treatment of upper urinary tract urothelial carcinoma (UTUC) combined with bladder cancer (BCa) by laparoscopic simultaneous radical cystectomy and nephroureterectomy (RCNU).

Methods: The clinical data of patients admitted to Peking University Third Hospital for laparoscopic RCNU surgery from January 2009 to September 2023 were analyzed retrospectively. Based on the same gender, age (±5 years), history of uroepithelial tumors, underlying diseases, T-stage, N-stage, M-stage, American Society of Anesthesiologists (ASA) score, Charlson comorbidity index, and body mass index (BMI) (±5), 34 patients with RCNU were matched 1 ∶1 with patients with bladder cancer who underwent laparoscopic radical cystectomy (RC) alone. Kaplan-Meier survival analysis was used to calculate patient survival, and Cox proportional regression risk model was used to analyze clinical factors affecting prognosis.

Results: Of the 68 patients enrolled, the follow-up rate was 100% with a median follow-up time of 27.0 (11.7, 60.2) months. Comparison of intraoperative conditions (including operation time, estimated intraoperative bleeding, intra-operative blood transfusion, etc.) between the two groups of patients showed no significant difference (P>0.05). Comparison of preoperative creatinine and postoperative creatinine between the two groups of patients showed significant differences (P < 0.05). The perioperative Clavien grade Ⅲ-Ⅳ complication rates were 2.9% (1/34) in the RC group and 5.9% (2/34) in the RCNU group. There was no significant difference in terms of perioperative complications between the two groups. Overall survival was significantly lower in the patients receiving RCNU compared with the matched group receiving RC alone (P < 0.05). Cox regression analysis suggested that two factors, high N stage and high postoperative creatinine, were independent risk factors affecting the prognosis of patients in the 2 groups (P < 0.05).

Conclusion: The overall survival prognosis of patients undergoing RCNU surgery was worse compared with laparoscopic RC surgery alone during the same period. There was no clinically significant difference between the two groups in terms of operation time, intraoperative bleeding, and perioperative complications, and there were clinically significant differences in preoperative renal function and post-operative renal function.

目的:探讨腹腔镜下膀胱根治术联合肾输尿管切除术(RCNU)治疗上尿路尿路上皮癌(UTUC)合并膀胱癌(BCa)的安全性及影响预后的因素。方法:回顾性分析2009年1月至2023年9月北京大学第三医院腹腔镜RCNU手术患者的临床资料。根据相同性别、年龄(±5岁)、尿路上皮肿瘤病史、基础疾病、t分期、n分期、m分期、美国麻醉学会(ASA)评分、Charlson合病指数和体重指数(BMI)(±5),将34例RCNU患者与单独行腹腔镜根治性膀胱切除术(RC)的膀胱癌患者进行1∶1的配对。采用Kaplan-Meier生存分析计算患者生存,采用Cox比例回归风险模型分析影响预后的临床因素。结果:入组的68例患者,随访率为100%,中位随访时间为27.0(11.7,60.2)个月。两组患者术中情况(包括手术时间、术中预估出血量、术中输血量等)比较差异无统计学意义(P < 0.05)。两组患者术前、术后肌酐比较,差异有统计学意义(P < 0.05)。RC组围手术期Clavien级Ⅲ-Ⅳ并发症发生率为2.9% (1/34),RCNU组为5.9%(2/34)。两组围手术期并发症无明显差异。接受RCNU的患者总生存率明显低于单独接受RCNU的匹配组(P < 0.05)。Cox回归分析提示,高N期和术后高肌酐是影响两组患者预后的独立危险因素(P < 0.05)。结论:同期行RCNU手术的患者总体生存预后较单纯腹腔镜下RC手术差。两组在手术时间、术中出血、围术期并发症等方面均无明显临床差异,术前肾功能、术后肾功能差异有显著临床意义。
{"title":"[Prognostic analysis of laparoscopic simultaneous radical cystectomy and nephroureterectomy].","authors":"Shenmo Li, Dandan Su, Jiyu Lin, Haodong Song, Lulin Ma, Xiaofei Hou, Guoliang Wang, Hongxian Zhang, Jianfei Ye, Shudong Zhang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the safety and prognostic factors influencing the treatment of upper urinary tract urothelial carcinoma (UTUC) combined with bladder cancer (BCa) by laparoscopic simultaneous radical cystectomy and nephroureterectomy (RCNU).</p><p><strong>Methods: </strong>The clinical data of patients admitted to Peking University Third Hospital for laparoscopic RCNU surgery from January 2009 to September 2023 were analyzed retrospectively. Based on the same gender, age (±5 years), history of uroepithelial tumors, underlying diseases, T-stage, N-stage, M-stage, American Society of Anesthesiologists (ASA) score, Charlson comorbidity index, and body mass index (BMI) (±5), 34 patients with RCNU were matched 1 ∶1 with patients with bladder cancer who underwent laparoscopic radical cystectomy (RC) alone. Kaplan-Meier survival analysis was used to calculate patient survival, and Cox proportional regression risk model was used to analyze clinical factors affecting prognosis.</p><p><strong>Results: </strong>Of the 68 patients enrolled, the follow-up rate was 100% with a median follow-up time of 27.0 (11.7, 60.2) months. Comparison of intraoperative conditions (including operation time, estimated intraoperative bleeding, intra-operative blood transfusion, <i>etc</i>.) between the two groups of patients showed no significant difference (<i>P></i>0.05). Comparison of preoperative creatinine and postoperative creatinine between the two groups of patients showed significant differences (<i>P</i> < 0.05). The perioperative Clavien grade Ⅲ-Ⅳ complication rates were 2.9% (1/34) in the RC group and 5.9% (2/34) in the RCNU group. There was no significant difference in terms of perioperative complications between the two groups. Overall survival was significantly lower in the patients receiving RCNU compared with the matched group receiving RC alone (<i>P</i> < 0.05). Cox regression analysis suggested that two factors, high N stage and high postoperative creatinine, were independent risk factors affecting the prognosis of patients in the 2 groups (<i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>The overall survival prognosis of patients undergoing RCNU surgery was worse compared with laparoscopic RC surgery alone during the same period. There was no clinically significant difference between the two groups in terms of operation time, intraoperative bleeding, and perioperative complications, and there were clinically significant differences in preoperative renal function and post-operative renal function.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 5","pages":"961-966"},"PeriodicalIF":0.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549371/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353787","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comparison of efficacy and safety of oral mucosa grafts and acellular dermal matrix grafts in the treatment of long-segment urethral stricture]. 口腔黏膜移植与脱细胞真皮基质移植治疗尿道长段狭窄的疗效及安全性比较。
Q3 Medicine Pub Date : 2025-10-18
Wenyuan Leng, Duan Gao, Xiaoyu Li, Wei Zuo, Weimin Hu, Zhenpeng Zhu, Chunru Xu, Jian Lin, Xuesong Li

Objective: To investigate the differential efficacy and safety profiles of oral mucosa (OM) grafts compared with acellular dermal matrix (ADM) grafts in the surgical management of long-segment urethral strictures.

Methods: A retrospective cohort study was conducted involving 27 patients who underwent graft urethroplasty for long-segment urethral strictures in Peking University First Hospital, spanning from May 2010 to September 2023. The patient cohort comprised 14 individuals who received OM grafts and 13 who underwent ADM grafts. The participants were stratified into two groups based on the type of grafts material utilized during surgery. The demographic and clinical baseline characteristics included an average age of (43.3±14.0) years in the OM group and (54.2±15.9) years in the ADM group. The mean body mass index (BMI) for the respective groups were (24.7±4.3) kg/m2 for OM and (25.4±4.8) kg/m2 for ADM. Etiological differences were noted, with idiopathic causes predominantly in the OM cohort and lichen sclerosus in the ADM cohort.

Results: The surgical interventions were successfully executed for all the patients. The median stricture length was 4.5 (2.5, 9.0) cm for the OM group and 5.0 (2.0, 14.0) cm for the ADM group (P=0.555). The median operative duration was 160 (71, 221) min for the OM group and 134 (112, 274) min for the ADM group (P=0.065). The catheterization durations was 1.5 (1.0, 6.0) months for the OM group and 3.0 (1.0, 3.0) months for the ADM group. The median postoperative follow-up duration was 12.5 (1.0, 170.0) months for the OM group and 59.0 (3.0, 142.0) months for the ADM group. The surgical success rates were 50.00% in the OM group and 53.85% in the ADM group. No statistically significant differences were observed in postoperative quality of life (QoL) or international prostate symptom score (IPSS) at the final follow-up. The stricture-free survival rates did not differ significantly (HR=0.875, 95%CI: 0.507-1.511, P=0.6). In terms of safety, three patients in the OM group experienced sexual dysfunction, and two had oral complications, whereas the ADM group had one case of postoperative infection.

Conclusion: The findings suggest that ADM grafts are comparable to OM grafts in terms of efficacy and safety for the treatment of long-segment urethral strictures, including complex cases attributed to lichen sclerosus. However, given the small sample size of this study, the above conclusions may have certain limitations. Larger cohort studies will be needed in the future to further validate these findings.

目的:探讨口腔黏膜(OM)移植与脱细胞真皮基质(ADM)移植治疗尿道长段狭窄的疗效和安全性差异。方法:对2010年5月至2023年9月在北京大学第一医院行移植尿道成形术治疗长段尿道狭窄的27例患者进行回顾性队列研究。患者队列包括14名接受OM移植的患者和13名接受ADM移植的患者。参与者根据手术中使用的移植物材料类型分为两组。人口学和临床基线特征包括OM组的平均年龄为(43.3±14.0)岁,ADM组的平均年龄为(54.2±15.9)岁。两组的平均体重指数(BMI)分别为OM组(24.7±4.3)kg/m2和ADM组(25.4±4.8)kg/m2。病因学差异明显,OM组以特发性原因为主,ADM组以硬化地衣为主。结果:所有患者均成功完成手术干预。OM组中位狭窄长度为4.5 (2.5,9.0)cm, ADM组中位狭窄长度为5.0 (2.0,14.0)cm (P=0.555)。OM组的中位手术时间为160 (71,221)min, ADM组的中位手术时间为134 (112,274)min (P=0.065)。OM组插管时间为1.5(1.0,6.0)个月,ADM组插管时间为3.0(1.0,3.0)个月。术后中位随访时间OM组为12.5(1.0,170.0)个月,ADM组为59.0(3.0,142.0)个月。手术成功率OM组为50.00%,ADM组为53.85%。术后生活质量(QoL)或国际前列腺症状评分(IPSS)在最终随访时无统计学差异。无狭窄生存率差异无统计学意义(HR=0.875, 95%CI: 0.507 ~ 1.511, P=0.6)。安全性方面,OM组有3例患者出现性功能障碍,2例出现口腔并发症,ADM组有1例术后感染。结论:ADM移植与OM移植治疗长段尿道狭窄的疗效和安全性相当,包括复杂的硬苔性尿道狭窄病例。但是,由于本研究样本量较小,上述结论可能存在一定的局限性。未来需要更大规模的队列研究来进一步验证这些发现。
{"title":"[Comparison of efficacy and safety of oral mucosa grafts and acellular dermal matrix grafts in the treatment of long-segment urethral stricture].","authors":"Wenyuan Leng, Duan Gao, Xiaoyu Li, Wei Zuo, Weimin Hu, Zhenpeng Zhu, Chunru Xu, Jian Lin, Xuesong Li","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the differential efficacy and safety profiles of oral mucosa (OM) grafts compared with acellular dermal matrix (ADM) grafts in the surgical management of long-segment urethral strictures.</p><p><strong>Methods: </strong>A retrospective cohort study was conducted involving 27 patients who underwent graft urethroplasty for long-segment urethral strictures in Peking University First Hospital, spanning from May 2010 to September 2023. The patient cohort comprised 14 individuals who received OM grafts and 13 who underwent ADM grafts. The participants were stratified into two groups based on the type of grafts material utilized during surgery. The demographic and clinical baseline characteristics included an average age of (43.3±14.0) years in the OM group and (54.2±15.9) years in the ADM group. The mean body mass index (BMI) for the respective groups were (24.7±4.3) kg/m<sup>2</sup> for OM and (25.4±4.8) kg/m<sup>2</sup> for ADM. Etiological differences were noted, with idiopathic causes predominantly in the OM cohort and lichen sclerosus in the ADM cohort.</p><p><strong>Results: </strong>The surgical interventions were successfully executed for all the patients. The median stricture length was 4.5 (2.5, 9.0) cm for the OM group and 5.0 (2.0, 14.0) cm for the ADM group (<i>P</i>=0.555). The median operative duration was 160 (71, 221) min for the OM group and 134 (112, 274) min for the ADM group (<i>P</i>=0.065). The catheterization durations was 1.5 (1.0, 6.0) months for the OM group and 3.0 (1.0, 3.0) months for the ADM group. The median postoperative follow-up duration was 12.5 (1.0, 170.0) months for the OM group and 59.0 (3.0, 142.0) months for the ADM group. The surgical success rates were 50.00% in the OM group and 53.85% in the ADM group. No statistically significant differences were observed in postoperative quality of life (QoL) or international prostate symptom score (IPSS) at the final follow-up. The stricture-free survival rates did not differ significantly (<i>HR</i>=0.875, 95%<i>CI</i>: 0.507-1.511, <i>P</i>=0.6). In terms of safety, three patients in the OM group experienced sexual dysfunction, and two had oral complications, whereas the ADM group had one case of postoperative infection.</p><p><strong>Conclusion: </strong>The findings suggest that ADM grafts are comparable to OM grafts in terms of efficacy and safety for the treatment of long-segment urethral strictures, including complex cases attributed to lichen sclerosus. However, given the small sample size of this study, the above conclusions may have certain limitations. Larger cohort studies will be needed in the future to further validate these findings.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 5","pages":"975-979"},"PeriodicalIF":0.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549363/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Establishment and validation of a risk prediction model for scoliosis after Nuss procedure in children and young adults with pectus excavatum]. [儿童和青年漏斗胸患者Nuss手术后脊柱侧凸风险预测模型的建立和验证]。
Q3 Medicine Pub Date : 2025-10-18
Bowen Li, Qiang Zhang, Yixin Sun

Objective: To identify the risk factors associated with the development of post-Nuss procedure scoliosis in pectus excavatum patients and to establish a relevant predictive model.

Methods: A retro-spective review was conducted on pectus excavatum patients who underwent Nuss procedure in Department of Thoracic Surgery at Beijing Jishuitan Hospital between January 2018 and February 2023. We gathered the patient demographic information (including age, sex, height, weight, and body mass index) and diagnostic imaging results (echocardiogram, chest CT scan, full-spine radiography, and PA/lateral chest X-rays), and measurements of Haller index, asymmetry index, sternal torsion angle (STA) index, and Cobb angle changes. The risk of post-Nuss procedure scoliosis was assessed. Cox regression analysis was performed to identify independent risk factors for scoliosis development in the pectus excavatum patients. Based on the results of the Cox regression analysis, a risk prediction model was established, and its specific predictive performance was assessed through internal cross-validation.

Results: A total of 59 pectus excavatum patients who underwent Nuss procedure were included after applying inclusion and exclusion criteria. The median follow-up duration was 6.84 months, and the follow-up results showed significant improvements in Haller index, STA index, and asymmetry index postoperatively. Twelve patients developed scoliosis 3 months after Nuss procedure, while 47 patients did not, the incidence of scoliosis was 20.3%. Cox regression analysis identified preoperative pulmonary artery hypertension and preoperative asymmetry index as independent risk factors for post-Nuss procedure scoliosis. A predictive model was constructed based on single-factor Cox regression analysis results, incorporating age, height, weight, body mass index, preoperative pulmonary artery hypertension, preoperative Haller index, STA index, asymmetry index, and Cobb angle. The receiver operating characteristic (ROC) curve was plotted, and the area under the curve (AUC) for the overall predictive model was calculated to be 0.995. A calibration curve demonstrated good alignment between predicted values and actual values.

Conclusion: Nuss procedure achieved favorable clinical outcomes. However, postoperative scoliosis emerged as a significant complication with a high incidence rate. Pulmonary artery hypertension and asymmetry index were independent predictors of post-Nuss procedure scoliosis. The predictive model developed in this study demonstrated robust performance in estimating the risk of postoperative scoliosis.

目的:探讨nuss手术后漏斗胸侧凸发生的相关危险因素,并建立相应的预测模型。方法:回顾性分析2018年1月至2023年2月在北京积水潭医院胸外科行Nuss手术的漏斗胸患者。我们收集了患者的人口学信息(包括年龄、性别、身高、体重和体重指数)和诊断成像结果(超声心动图、胸部CT扫描、全脊柱x线片和PA/侧位胸部x线片),以及Haller指数、不对称指数、胸骨扭转角(STA)指数和Cobb角变化的测量值。评估nuss手术后脊柱侧凸的风险。采用Cox回归分析确定漏斗胸患者脊柱侧凸发展的独立危险因素。根据Cox回归分析结果,建立风险预测模型,并通过内部交叉验证评估其具体预测性能。结果:59例漏斗胸患者经纳入和排除标准后,均行Nuss手术。中位随访时间为6.84个月,术后Haller指数、STA指数、不对称指数均有明显改善。Nuss手术后3个月发生侧凸12例,无侧凸47例,侧凸发生率为20.3%。Cox回归分析发现术前肺动脉高压和术前不对称指数是nuss手术后脊柱侧凸的独立危险因素。结合年龄、身高、体重、体质指数、术前肺动脉高压、术前Haller指数、STA指数、不对称指数、Cobb角等因素,构建单因素Cox回归分析预测模型。绘制受试者工作特征(ROC)曲线,计算总体预测模型的曲线下面积(AUC)为0.995。校正曲线显示预测值与实际值吻合良好。结论:Nuss手术取得了良好的临床效果。然而,术后脊柱侧凸是一个发生率很高的重要并发症。肺动脉高压和不对称指数是nuss手术后脊柱侧凸的独立预测因子。本研究中建立的预测模型在估计术后脊柱侧凸风险方面表现出稳健的性能。
{"title":"[Establishment and validation of a risk prediction model for scoliosis after Nuss procedure in children and young adults with pectus excavatum].","authors":"Bowen Li, Qiang Zhang, Yixin Sun","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To identify the risk factors associated with the development of post-Nuss procedure scoliosis in pectus excavatum patients and to establish a relevant predictive model.</p><p><strong>Methods: </strong>A retro-spective review was conducted on pectus excavatum patients who underwent Nuss procedure in Department of Thoracic Surgery at Beijing Jishuitan Hospital between January 2018 and February 2023. We gathered the patient demographic information (including age, sex, height, weight, and body mass index) and diagnostic imaging results (echocardiogram, chest CT scan, full-spine radiography, and PA/lateral chest X-rays), and measurements of Haller index, asymmetry index, sternal torsion angle (STA) index, and Cobb angle changes. The risk of post-Nuss procedure scoliosis was assessed. Cox regression analysis was performed to identify independent risk factors for scoliosis development in the pectus excavatum patients. Based on the results of the Cox regression analysis, a risk prediction model was established, and its specific predictive performance was assessed through internal cross-validation.</p><p><strong>Results: </strong>A total of 59 pectus excavatum patients who underwent Nuss procedure were included after applying inclusion and exclusion criteria. The median follow-up duration was 6.84 months, and the follow-up results showed significant improvements in Haller index, STA index, and asymmetry index postoperatively. Twelve patients developed scoliosis 3 months after Nuss procedure, while 47 patients did not, the incidence of scoliosis was 20.3%. Cox regression analysis identified preoperative pulmonary artery hypertension and preoperative asymmetry index as independent risk factors for post-Nuss procedure scoliosis. A predictive model was constructed based on single-factor Cox regression analysis results, incorporating age, height, weight, body mass index, preoperative pulmonary artery hypertension, preoperative Haller index, STA index, asymmetry index, and Cobb angle. The receiver operating characteristic (ROC) curve was plotted, and the area under the curve (AUC) for the overall predictive model was calculated to be 0.995. A calibration curve demonstrated good alignment between predicted values and actual values.</p><p><strong>Conclusion: </strong>Nuss procedure achieved favorable clinical outcomes. However, postoperative scoliosis emerged as a significant complication with a high incidence rate. Pulmonary artery hypertension and asymmetry index were independent predictors of post-Nuss procedure scoliosis. The predictive model developed in this study demonstrated robust performance in estimating the risk of postoperative scoliosis.</p>","PeriodicalId":8790,"journal":{"name":"北京大学学报(医学版)","volume":"57 5","pages":"941-946"},"PeriodicalIF":0.0,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12549355/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145353623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
北京大学学报(医学版)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1